Tag: Dis-Chem; Ivan Saltzman; Rui Morais; private healthcare; pharmacy retail; healthcare investment

  • Dis-Chem succession enters a new phase

    Dis-Chem succession has entered a decisive phase after founder Ivan Saltzman and his family stepped away from formal management and board roles at the healthcare retailer. Saltzman, 76, had initially been nominated for election as a non-executive director. Dis-Chem’s AGM notice, issued on 30 June, included a resolution confirming his proposed appointment. However, on 24 July the group announced that…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in